Greater hunger and less restraint predict weight loss success with phentermine treatment

Phentermine is thought to cause weight loss through a reduction in hunger. It was hypothesized that higher hunger ratings would predict greater weight loss with phentermine.

[1]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[2]  C. Apovian,et al.  Guidelines (2013) for managing overweight and obesity in adults , 2014 .

[3]  Young Sik Kim,et al.  Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity , 2013, Korean journal of family medicine.

[4]  Brian E. Vestal,et al.  Eating-related behaviors and appetite during energy imbalance in obese-prone and obese-resistant individuals , 2013, Appetite.

[5]  G. Bray,et al.  Pharmacologic Treatment Options for Obesity: What Is Old Is New Again , 2013, Current Hypertension Reports.

[6]  J. Daudin,et al.  Characterization of the Three-Factor Eating Questionnaire scores of a young French cohort , 2012, Appetite.

[7]  F. Greenway,et al.  Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long‐Term Phentermine Pharmacotherapy for Obesity , 2011, Obesity.

[8]  J. Kang,et al.  Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse‐controlled release for obesity , 2010, Diabetes, obesity & metabolism.

[9]  E. Boyland,et al.  Pharmacological management of appetite expression in obesity , 2010, Nature Reviews Endocrinology.

[10]  G. Bray.  Lifestyle and pharmacological approaches to weight loss: efficacy and safety. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  R. Eckel.  Clinical practice. Nonsurgical management of obesity in adults. , 2008, The New England journal of medicine.

[12]  V. Drapeau,et al.  Appetite sensations and satiety quotient: Predictors of energy intake and weight loss , 2007, Appetite.

[13]  H. Kang,et al.  Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People , 2006, Yonsei medical journal.

[14]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[15]  E. Colman.  Anorectics on Trial: A Half Century of Federal Regulation of Prescription Appetite Suppressants , 2005, Annals of Internal Medicine.

[16]  L. Kaplan,et al.  Pharmacologic therapies for obesity. , 2010, Gastroenterology clinics of North America.

[17]  V. Drapeau,et al.  Appetite sensations as a marker of overall intake , 2005, British Journal of Nutrition.

[18]  Meghan L Butryn,et al.  Efficacy of lifestyle modification for long-term weight control. , 2004, Obesity research.

[19]  Susan L. Johnson,et al.  Effects of short-term overfeeding on hunger, satiety, and energy intake in thin and reduced-obese individuals , 2004, Appetite.

[20]  J. Wardle,et al.  Socioeconomic gradient in body size and obesity among women: the role of dietary restraint, disinhibition and hunger in the Whitehall II study , 2004, International Journal of Obesity.

[21]  J. Després,et al.  Eating behaviors and indexes of body composition in men and women from the Québec family study. , 2003, Obesity research.

[22]  R. Stafford,et al.  National trends in antiobesity medication use. , 2003, Archives of internal medicine.

[23]  R. Roubenoff,et al.  Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y. , 2002, The American journal of clinical nutrition.

[24]  R Stratton,et al.  The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings , 2000, British Journal of Nutrition.

[25]  C Ayyad,et al.  Long‐term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999 , 2000, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[26]  G. Bray,et al.  Association of Body Mass with Dietary Restraint and Disinhibition , 1995, Appetite.

[27]  F. Pi-Sunyer,et al.  The Use of Areas Under Curves in Diabetes Research , 1995, Diabetes Care.

[28]  D. Garner,et al.  The Eating Attitudes Test: psychometric features and clinical correlates , 1982, Psychological Medicine.

[29]  Bhalla Ip,et al.  A controlled trial of phentermine in obese diabetic patients. , 1977 .

[30]  A. P. Truant,et al.  Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study. , 1972, Current therapeutic research, clinical and experimental.

[31]  L. J. Duncan,et al.  Comparison of continuous and intermittent anorectic therapy in obesity. , 1968, British medical journal.

[32]  G. Beeson,et al.  in adults with , 2019 .

[33]  L. Kaplan.  Pharmacologic therapies for obesity. , 2010, Gastroenterology clinics of North America.

[34]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[35]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[36]  A. Astrup,et al.  Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies , 2000, International Journal of Obesity.

[37]  A. Stunkard,et al.  The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. , 1985, Journal of psychosomatic research.

[38]  J. Vallé-Jones,et al.  A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice. , 1983, Pharmatherapeutica.

[39]  C. J. Campbell,et al.  A controlled trial of phentermine in obese diabetic patients. , 1977, The Practitioner.